Price Alert

PureTech Health (PRTC)

NASDAQ: PRTC · Real-Time Price · USD

16.10

0.24 (1.49%)

At close: Sep 05, 2025, 3:50 PM

16.18

0.53%

After-hours: Sep 05, 2025, 04:04 PM EDT

PureTech Health Statistics

Share Statistics

PureTech Health has 24.17M shares outstanding. The number of shares has increased by 0.33% in one year.

Shares Outstanding	24.17M
Shares Change (YoY)	0.33%
Shares Change (QoQ)	0%
Owned by Institutions (%)	0.15%
Shares Floating	16.57M
Failed to Deliver (FTD) Shares	84
FTD / Avg. Volume	2.04%

Short Selling Information

The latest short interest is 4.9K, so 0.02% of the outstanding shares have been sold short.

Short Interest	4.9K
Short % of Shares Out	0.02%
Short % of Float	0.02%
Short Ratio (days to cover)	1.3

Valuation Ratios

The PE ratio is 9.3 and the forward PE ratio is -3.71. PureTech Health's PEG ratio is -0.09.

PE Ratio	9.3
Forward PE	-3.71
PS Ratio	115.36
Forward PS	7.9
PB Ratio	1.2
P/FCF Ratio	-3.7
PEG Ratio	-0.09

Financial Ratio History

Enterprise Valuation

PureTech Health has an Enterprise Value (EV) of 4.72B.

EV / Sales	1093.77
EV / EBITDA	126.25
EV / EBIT	-35.12
EV / FCF	-35.12

Financial Position

The company has a current ratio of 9.33, with a Debt / Equity ratio of 0.05.

Current Ratio	9.33
Quick Ratio	9.33
Debt / Equity	0.05
Debt / EBITDA	0.6
Debt / FCF	-0.17
Interest Coverage	-13.56

Financial Efficiency

Return on Equity is 12.9% and Return on Invested Capital is -27.95%.

Return on Equity	12.9%
Return on Assets	8.88%
Return on Invested Capital	-27.95%
Revenue Per Employee	$53.94K
Profits Per Employee	$668.88K
Employee Count	80
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-4.01M
Effective Tax Rate	-16.86%

Stock Price Statistics

The stock price has increased by -20.92% in the last 52 weeks. The beta is 0.82, so PureTech Health's price volatility has been higher than the market average.

Beta	0.82
52-Week Price Change	-20.92%
50-Day Moving Average	18.08
200-Day Moving Average	18.47
Relative Strength Index (RSI)	38.73
Average Volume (20 Days)	4,124

Income Statement

In the last 12 months, PureTech Health had revenue of 4.32M and earned 53.51M in profits. Earnings per share was 2.

Revenue	4.32M
Gross Profit	1.26M
Operating Income	-136.09M
Net Income	53.51M
EBITDA	37.38M
EBIT	33.81M
Earnings Per Share (EPS)	2

Full Income Statement

Balance Sheet

The company has 280.64M in cash and 22.36M in debt, giving a net cash position of 258.28M.

Cash & Cash Equivalents	280.64M
Total Debt	22.36M
Net Cash	258.28M
Retained Earnings	32.49M
Total Assets	602.63M
Working Capital	344.87M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -134.37M and capital expenditures -11K, giving a free cash flow of -134.38M.

Operating Cash Flow	-134.37M
Capital Expenditures	-11K
Free Cash Flow	-134.38M
FCF Per Share	-0.5

Full Cash Flow Statement

Margins

Gross margin is 29.13%, with operating and profit margins of -3154% and 1240.09%.

Gross Margin	29.13%
Operating Margin	-3154%
Pretax Margin	550.96%
Profit Margin	1240.09%
EBITDA Margin	866.33%
EBIT Margin	-3154%
FCF Margin	-3114.25%

Dividends & Yields

PRTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	10.75%
FCF Yield	-2.7%

Dividend Details

Analyst Forecast

The average price target for PRTC is $45, which is 179.5% higher than the current price. The consensus rating is "Buy".

Price Target	$45
Price Target Difference	179.5%
Analyst Consensus	Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$50
Lynch Upside	210.56%
Graham Number	2.62
Graham Upside	-83.73%

Scores

Altman Z-Score	1.89
Piotroski F-Score	4